2020 Pennsylvania Tuberculosis Update

COURSE DESCRIPTION & OVERALL GOAL
This conference will address current and emerging issues in TB. The purpose of this training is to increase awareness and knowledge amongst providers on the current guidelines for the treatment of TB infection, the new guidelines for the treatment of drug-resistant tuberculosis, and the importance of managing adverse reactions during treatment for TB.

AGENDA

October 6, 2020
10:30 AM – 12:00 PM - Updated Guidelines for the Treatment of LTBI
Edward Zuroweste, MD and George McSherry, MD

2:00 – 3:30 PM - New Guidelines for the Treatment of Drug-Resistant TB
Barbara Seaworth, MD and Leonard Berkowitz, MD

October 7, 2020
1:30 – 3:00 PM - Recognizing and Managing Adverse Reactions from Anti-
Tuberculosis Drug Therapy
Henry Fraimow, MD

WHO SHOULD ATTEND
This conference is open to physicians, nurses, public health staff, and other health care workers who manage patients at risk for or diagnosed with TB infection or disease.

WHY COURSE IS NEEDED
As the incidence of TB continues to decline, maintaining clinical expertise is particularly challenging, especially as the cases are more complex to diagnosis and manage. Ongoing training and education are important for clinicians so they can develop and enhance skills in the diagnosis of TB, follow recommended treatment guidelines, and effectively manage complex cases.

OBJECTIVES
Upon completion of this conference, participants should be better able to:

• Employ updated guidance, best practice, and patient-centered strategies to guide patients towards initiation and completion of LTBI treatment.

• Outline best practices in the treatment of LTBI in children and adolescents.

• Utilize new guidance to initiate appropriate patient-centered treatment and improve treatment outcomes for patients with drug-resistant TB.

• Effectively recognize and address adverse drug reactions in patients on TB treatment.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire training and complete an evaluation.

CONTINUING EDUCATION INFORMATION
In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the Pennsylvania Department of Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 4.5 contact hours (60 minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

DISCLOSURE POLICY
All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made available to the audience at the time of the activity.

REGISTRATION INFORMATION & FEE
There is no fee for this conference.

Register to attend here.
We reserve the right to close registration early or cancel late registrants due to limits on capacity.

FUNDING DISCLOSURE
Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.
If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Olivia Dupont at od94@njms.rutgers.edu